vs
Side-by-side financial comparison of BLUE OWL CAPITAL INC. (OWL) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $755.6M, roughly 1.5× BLUE OWL CAPITAL INC.). BLUE OWL CAPITAL INC. runs the higher net margin — 6.3% vs -127.8%, a 134.1% gap on every dollar of revenue. On growth, BLUE OWL CAPITAL INC. posted the faster year-over-year revenue change (19.7% vs -2.5%). BLUE OWL CAPITAL INC. produced more free cash flow last quarter ($359.1M vs $148.6M). Over the past eight quarters, BLUE OWL CAPITAL INC.'s revenue compounded faster (21.3% CAGR vs 1.3%).
Blue Owl Capital Inc. is an American alternative investment asset management company that is listed on the New York Stock Exchange under the ticker symbol: "OWL". Headquartered in New York City, it has additional offices around the world, including London, Dubai, and Hong Kong.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
OWL vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $755.6M | $1.1B |
| Net Profit | $47.7M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | 22.2% | -116.0% |
| Net Margin | 6.3% | -127.8% |
| Revenue YoY | 19.7% | -2.5% |
| Net Profit YoY | 129.8% | -3093.9% |
| EPS (diluted) | $0.07 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $755.6M | $1.1B | ||
| Q3 25 | $728.0M | $1.0B | ||
| Q2 25 | $703.1M | $1.1B | ||
| Q1 25 | $683.5M | $1.0B | ||
| Q4 24 | $631.4M | $1.1B | ||
| Q3 24 | $600.9M | $1.1B | ||
| Q2 24 | $549.8M | $1.1B | ||
| Q1 24 | $513.3M | $1.1B |
| Q4 25 | $47.7M | $-1.4B | ||
| Q3 25 | $6.3M | $7.5M | ||
| Q2 25 | $17.4M | $-8.4M | ||
| Q1 25 | $7.4M | $-6.4M | ||
| Q4 24 | $20.7M | $-44.4M | ||
| Q3 24 | $29.8M | $-21.0M | ||
| Q2 24 | $33.9M | $-108.4M | ||
| Q1 24 | $25.1M | $2.0M |
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | — | 33.1% |
| Q4 25 | 22.2% | -116.0% | ||
| Q3 25 | 7.6% | 7.0% | ||
| Q2 25 | 12.0% | 4.3% | ||
| Q1 25 | 5.9% | 4.5% | ||
| Q4 24 | 11.7% | 10.0% | ||
| Q3 24 | 18.7% | 7.4% | ||
| Q2 24 | 28.4% | -2.5% | ||
| Q1 24 | 24.7% | -5.1% |
| Q4 25 | 6.3% | -127.8% | ||
| Q3 25 | 0.9% | 0.7% | ||
| Q2 25 | 2.5% | -0.8% | ||
| Q1 25 | 1.1% | -0.6% | ||
| Q4 24 | 3.3% | -3.9% | ||
| Q3 24 | 5.0% | -1.9% | ||
| Q2 24 | 6.2% | -10.2% | ||
| Q1 24 | 4.9% | 0.2% |
| Q4 25 | $0.07 | $-10.23 | ||
| Q3 25 | $0.01 | $0.05 | ||
| Q2 25 | $0.02 | $-0.06 | ||
| Q1 25 | $0.00 | $-0.05 | ||
| Q4 24 | $0.06 | $-0.32 | ||
| Q3 24 | $0.04 | $-0.15 | ||
| Q2 24 | $0.06 | $-0.79 | ||
| Q1 24 | $0.04 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $194.5M | — |
| Total DebtLower is stronger | $3.3B | — |
| Stockholders' EquityBook value | $2.2B | $2.9B |
| Total Assets | $12.5B | $8.5B |
| Debt / EquityLower = less leverage | 1.51× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $194.5M | — | ||
| Q3 25 | $137.3M | $432.1M | ||
| Q2 25 | $117.6M | $454.2M | ||
| Q1 25 | $97.6M | $409.9M | ||
| Q4 24 | $152.1M | $558.8M | ||
| Q3 24 | $115.9M | $1.5B | ||
| Q2 24 | $436.8M | $542.8M | ||
| Q1 24 | $155.8M | $658.5M |
| Q4 25 | $3.3B | — | ||
| Q3 25 | $3.2B | — | ||
| Q2 25 | $3.2B | — | ||
| Q1 25 | $3.2B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.5B | — | ||
| Q2 24 | $2.5B | — | ||
| Q1 24 | $2.1B | — |
| Q4 25 | $2.2B | $2.9B | ||
| Q3 25 | $2.3B | $4.4B | ||
| Q2 25 | $2.4B | $4.5B | ||
| Q1 25 | $2.3B | $4.4B | ||
| Q4 24 | $2.1B | $4.3B | ||
| Q3 24 | $2.0B | $4.6B | ||
| Q2 24 | $1.7B | $4.5B | ||
| Q1 24 | $1.6B | $4.7B |
| Q4 25 | $12.5B | $8.5B | ||
| Q3 25 | $12.5B | $10.1B | ||
| Q2 25 | $12.3B | $10.1B | ||
| Q1 25 | $12.3B | $9.8B | ||
| Q4 24 | $11.0B | $9.6B | ||
| Q3 24 | $10.8B | $11.2B | ||
| Q2 24 | $9.7B | $10.4B | ||
| Q1 24 | $9.0B | $10.6B |
| Q4 25 | 1.51× | — | ||
| Q3 25 | 1.41× | — | ||
| Q2 25 | 1.38× | — | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 1.22× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | 1.41× | — | ||
| Q1 24 | 1.26× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $382.9M | $175.4M |
| Free Cash FlowOCF − Capex | $359.1M | $148.6M |
| FCF MarginFCF / Revenue | 47.5% | 13.4% |
| Capex IntensityCapex / Revenue | 3.1% | 2.4% |
| Cash ConversionOCF / Net Profit | 8.03× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.2B | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $382.9M | $175.4M | ||
| Q3 25 | $433.1M | $51.7M | ||
| Q2 25 | $422.5M | $75.9M | ||
| Q1 25 | $17.6M | $-64.5M | ||
| Q4 24 | $324.0M | $312.6M | ||
| Q3 24 | $326.0M | $42.2M | ||
| Q2 24 | $302.3M | $9.5M | ||
| Q1 24 | $47.2M | $-1.4M |
| Q4 25 | $359.1M | $148.6M | ||
| Q3 25 | $422.5M | $29.8M | ||
| Q2 25 | $412.5M | $56.7M | ||
| Q1 25 | $4.2M | $-90.0M | ||
| Q4 24 | $310.1M | $274.9M | ||
| Q3 24 | $314.8M | $15.1M | ||
| Q2 24 | $269.4M | $-18.9M | ||
| Q1 24 | $41.1M | $-26.5M |
| Q4 25 | 47.5% | 13.4% | ||
| Q3 25 | 58.0% | 2.9% | ||
| Q2 25 | 58.7% | 5.4% | ||
| Q1 25 | 0.6% | -8.6% | ||
| Q4 24 | 49.1% | 24.2% | ||
| Q3 24 | 52.4% | 1.4% | ||
| Q2 24 | 49.0% | -1.8% | ||
| Q1 24 | 8.0% | -2.4% |
| Q4 25 | 3.1% | 2.4% | ||
| Q3 25 | 1.5% | 2.1% | ||
| Q2 25 | 1.4% | 1.8% | ||
| Q1 25 | 2.0% | 2.4% | ||
| Q4 24 | 2.2% | 3.3% | ||
| Q3 24 | 1.9% | 2.5% | ||
| Q2 24 | 6.0% | 2.7% | ||
| Q1 24 | 1.2% | 2.3% |
| Q4 25 | 8.03× | — | ||
| Q3 25 | 68.64× | 6.89× | ||
| Q2 25 | 24.25× | — | ||
| Q1 25 | 2.37× | — | ||
| Q4 24 | 15.62× | — | ||
| Q3 24 | 10.94× | — | ||
| Q2 24 | 8.91× | — | ||
| Q1 24 | 1.88× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OWL
| Credit Platform | $455.0M | 60% |
| GP Strategic Capital Platform | $157.0M | 21% |
| Administrative Service | $87.6M | 12% |
| IPI Partners LLC | $33.8M | 4% |
| Other | $22.2M | 3% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
